Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 99 shares at $1062.71 ($107K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($107k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1053.22 | 1 | $1K | 1.0% |
| 2 | $1058.90 | 1 | $1K | 1.0% |
| 3 | $1062.71 | 1 | $1K | 1.0% |
| 4 | $1065.39 | 6 | $6K | 5.9% |
| 5 | $1066.33 | 4 | $4K | 4.0% |
| 6 | $1067.53 | 1 |
| $1K |
| 1.0% |
| 7 | $1068.08 | 1 | $1K | 1.0% |
| 8 | $1070.46 | 4 | $4K | 4.0% |
| 9 | $1073.03 | 1 | $1K | 1.0% |
| 10 | $1074.34 | 1 | $1K | 1.0% |
| 11 | $1076.07 | 3 | $3K | 3.0% |
| 12 | $1080.06 | 1 | $1K | 1.0% |
| 13 | $1082.17 | 1 | $1K | 1.0% |
| 14 | $1083.57 | 1 | $1K | 1.0% |
| 15 | $1084.71 | 3 | $3K | 3.0% |
| 16 | $1085.71 | 3 | $3K | 3.0% |
| 17 | $1086.38 | 2 | $2K | 2.0% |
| 18 | $1087.54 | 2 | $2K | 2.0% |
| 19 | $1088.70 | 3 | $3K | 3.0% |
| 20 | $1089.64 | 7 | $8K | 7.1% |
| 21 | $1090.30 | 11 | $12K | 11.2% |
| 22 | $1091.47 | 13 | $14K | 13.2% |
| 23 | $1092.61 | 7 | $8K | 7.1% |
| 24 | $1093.39 | 7 | $8K | 7.1% |
| 25 | $1094.02 | 1 | $1K | 1.0% |
| 26 | $1095.35 | 3 | $3K | 3.1% |
| 27 | $1096.19 | 3 | $3K | 3.1% |
| 28 | $1097.69 | 3 | $3K | 3.1% |
| 29 | $1098.00 | 1 | $1K | 1.0% |
| 30 | $1099.65 | 3 | $3K | 3.1% |
| Total | $1085.53 avg | 99 | $107K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |